Cardiology, Peripheral Vascular & Vein MSO Platform Architecture
Consolidate clinical cardiology consult suites with high-margin Office-Based Labs (OBLs) and Ambulatory Surgery Centers (ASCs), capture outpatient cath lab migration, and command 13x–16x EBITDA multiples.
Cardiovascular care is experiencing a historic migration from inpatient hospital facilities into physician-owned Office-Based Labs (OBLs) and Ambulatory Surgery Centers (ASCs). Peripheral vascular interventions (PVIs), cardiac catheterization (CPT 93458), pacemaker placements, and endovenous radiofrequency ablation for chronic venous insufficiency generate exceptional margins under Medicare and commercial fee schedules. However, cardiology MSOs face severe regulatory scrutiny under Stark Law, Anti-Kickback Statute (AKS), and state Corporate Practice of Medicine doctrines. Kompanie LLP designs compliant cardiology MSO structures: separating professional clinical practices from high-capital OBL facility operations, structuring compliant physician equity models, and defending Fair Market Value (FMV) management fees.
Deliverables
- Dual-tier Friendly Cardiology PC and OBL/ASC Facility MSO corporate legal charters.
- OIG-compliant Office-Based Lab equipment lease safe harbor drafting.
- Cardiology wRVU productivity and rollover equity retention schedules.
- Commercial payer single-signature TIN integration and fee schedule parity review.
Execution phases
- Stage 1: Pre-LOI Regulatory & Clinical Due Diligence — Audit OBL facility leases, Stark IOASE compliance, medical necessity documentation for CPT 36475/36478, and physician referral flows.
- Stage 2: Friendly-PC & MSO Management Structuring — Draft state-specific Friendly Cardiology PC charters, comprehensive Master Management Services Agreements (MSA), and equipment leases.
- Stage 3: Outpatient Migration & Multiple Arbitrage — Syndicate ASC facility equity, transition hospital-based procedures to outpatient OBLs, and prepare for secondary sponsor recapitalization.
Diligence red flags
- Vein clinic platform billing bilateral cosmetic varicose vein treatments as medically necessary endovenous ablations without documented conservative compression therapy trials.
- Physician investors in cardiology OBL receiving direct distribution of facility fee profits tied to personal procedure referral volumes.
- Lack of clear clinical separation between OBL (place of service 11) and ASC (place of service 24) billing schedules causing dual-billing denials.
- High-acuity interventionalists departing post-close due to poorly structured wRVU compensation haircuts.
Frequently asked questions
What is the valuation multiple spread between solo cardiology practices and institutional MSOs?
Solo cardiology practices lacking procedural facilities trade at 4x to 6x EBITDA. Branded regional cardiology platforms combining clinical consults with accredited OBL/ASC surgical suites command 13x to 16x EBITDA from healthcare private equity sponsors.
How does an MSO ensure compliant vein ablation billing under Medicare LCDs?
Local Coverage Determinations require documented failure of at least 3 months of conservative compression therapy and duplex ultrasound proof of saphenous reflux exceeding 500 milliseconds before endovenous ablation can be billed.